Sitewide
UNC study questions FDA genetic-screening guidelines for cancer drug
Not everyone needs a genetic test before taking the cancer drug irinotecan, and the US Food and Drug Administration should modify its prescription guidelines to say so, according to researchers at the University of North Carolina at Chapel Hill.
Similar Articles On This Topic:
- UNC study firms up promise of potential new cervical cancer screening tool
- UNC study shows potential to revive abandoned cancer drug by nanoparticle drug delivery
- UNC study identifies genetic cause of most common form of breast cancer
- Study questions whether screening really cuts breast cancer deaths
- UNC study offers first clinical evidence of anti-cancer drug triggering viral infection
Popular Today:
Science 2.0:
- Science Can Save Crops, Forests And Endangered Animals By Doing This One Thing
- Organic Carbon In Meteorites Came From Mars
- Is That A Dragon In Your Berth Or Are You Just Happy To See Me?
- Are Anthropogenic Pressures Increasing The Speed Of Bacterial Evolution?
- From Towel Day To SpaceX And Transparency Grenades
Recent Articles:
Read Us On Your Kindle:
Create Your Own Releases:
Post new comment